MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) was featured in a NetworkNewsAudio audio press release highlighting the emerging potential of AI-powered voice analysis as a noninvasive method for intoxication detection. The editorial explores how speech-based diagnostics may offer rapid, real-time assessment of cognitive and physiological impairment by analyzing measurable vocal biomarkers such as tone, pitch, rhythm and articulation.
MindBio is a biotechnology company that is commercialising AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The Company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
This technology could transform workplace safety by providing noninvasive, instant screening for impairment, potentially reducing accidents and improving compliance with safety regulations. Traditional methods such as breathalyzers or blood tests are often invasive, time-consuming, and may not detect impairment from drugs other than alcohol. Voice analysis offers a rapid alternative that could be deployed in high-risk industries where even slight impairment can lead to catastrophic consequences.
For more details on the announcement, visit the full press release at https://nnw.fm/iRHnd. The latest news and updates relating to MBQIF are available in the company’s newsroom at https://nnw.fm/MBQIF.
